Livalo: payments to doctors
Payments that named Livalo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 32,229
- Transactions
- 137,604
- Average per transaction
- $15
The per-transaction average — $15 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 32,229 providers the average total is $64, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $2,052,308 | 100.0% |
| Lilly USA, LLC | $823 | 0.0% |